MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

PDL BioPharma Company Profile (NASDAQ:PDLI)

Consensus Ratings for PDL BioPharma (NASDAQ:PDLI) (?)
Ratings Breakdown: 1 Hold Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $5.00 (71.23% upside)

Analysts' Ratings History for PDL BioPharma (NASDAQ:PDLI)
Show:
DateFirmActionRatingPrice TargetActions
2/2/2016RBC CapitalLower Price TargetSector Perform$6.00 -> $5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2015RBC CapitalLower Price TargetSector Perform$7.00 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/16/2015RBC CapitalLower Price TargetSector Perform$8.00 -> $7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/20/2014Cowen and CompanyBoost Price Target$7.00 -> $8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 2/6/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha